Fred Hassan, Warburg Pincus Partner and Managing Director, discusses the latest pharmaceutical deals making headlines and believes Mylan and Perrigo are the most complementary for a deal.» Read More
Fred Hassan, Warburg Pincus Partner, talks about the way information technology is changing the face of modern medicine and transforming the health care industry.
CNBC's Meg Tirrell has details on the meeting today between President Obama and drugmakers to discuss how to improve health and treat disease.
Two new studies discuss turning stem cells into hair cells and transplanting them onto bald spots.
The sheer volume and pace of biotech offerings are causing some to question whether the sector is nearing the end of its years of buoyancy.
Researchers found that feeding a group of children a form of beneficial bacteria helped them overcome a potentially fatal food allergy.
Cathrin Petty, co-head of EMEA healthcare at JP Morgan, says the U.K. has the capacity to be a successful market for life sciences, and the year ahead for healthcare IPOs looks strong.
George Freeman MP, minister of life sciences in the U.K., says there's been a "resurgence" for life sciences and healthcare investment.
Steve Harris, CEO of Circassia, says his company is combating allergies by tackling how they affect people's immune systems, rather than simply making products that provide "symptomatic relief".
The heads of research at several large drugmakers have received mysterious invitations to the White House for a meeting Friday morning.
Bristol-Myers Squibb reported higher-than-expected earnings, helped by strong sales of its hepatitis C drugs and its Eliquis blood clot preventer.
Pfizer reported stronger-than-expected quarterly results as sales of vaccines and cancer drugs increased.
Cole Smead, portfolio manager at Smead Capital Management, discusses the strong U.S. dollar and how it will affect sectors like pharmaceuticals.
Novartis forecast sales and profits to grow at a faster pace this year driven by recent drug successes and its portfolio overhaul.
The ability to unfold a protein and return it to its original state could save money in everything from cancer research to food production.
A clinical trial of two experimental Ebola vaccines is expected to start in Liberia in the next couple of weeks, the NIH said.
Marvina is a premium cannabis provider that offers a monthly delivery service of marijuana to consumers in San Francisco.
Pharmaceutical giant Bristol-Myers Squibb named Dr. Giovanni Caforio as its new CEO on Tuesday.
The cost of a vaccination program is 68 times more expensive than is was in 2001. Doctors Without Borders wants companies to slash prices.
Discussing the current state of Europe at Davos 2015, Karl-Ludwig Kley, chairman of Merck says the lack of coordination and cohesion in European businesses is the current problem.Meanwhile political leaders need a wake-up call.
Regeneron Pharmaceuticals CEO Dr. Leonard Schleifer told CNBC on Tuesday that benefits companies should not try to practice medicine.
Get the best of CNBC in your inbox